Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center
A2 Biotherapeutics Inc.
Memorial Sloan Kettering Cancer Center
University of Nebraska
Adela, Inc
Elephas
Elephas
Palo Alto Veterans Institute for Research
Centre Hospitalier Universitaire de Besancon
University Health Network, Toronto
Massive Bio, Inc.
Delfi Diagnostics Inc.
Western University, Canada
A2 Biotherapeutics Inc.
Institut Bergonié
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Pfizer
University Health Network, Toronto
Taproot Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
DxTerity Diagnostics
University of Sydney
N.N. Petrov National Medical Research Center of Oncology
Sanguine Biosciences
IRCCS San Raffaele
Exact Sciences Corporation
Weprom
SpeciCare
M.D. Anderson Cancer Center
University of Zurich
CureOne
American College of Radiology Imaging Network
GlaxoSmithKline
GlaxoSmithKline
European Georges Pompidou Hospital
Amgen
M.D. Anderson Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Turin, Italy